| 1.1 | SITAGLIPTIN | 762240-92-6 | 3-(Trifluoromethyl)-5,6,7,8-Tetrahydro-[1,2,4]Triazolo[4,3-A]Pyrazine Hydrochloride | ANTI-DIABETIC |  |
| 1.2 | SITAGLIPTIN | 764667-65-4 | Sitagliptin Keto Amide Impurity//1-(3-(Trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butane-1,3-dione. | ANTI-DIABETIC | |
| 1.3 | SITAGLIPTIN | 767340-03-4 | Sitagliptin Enamine Impurity | ANTI-DIABETIC | |
| 1.4 | SITAGLIPTIN | 832817-56-7 | Sitagliptin Impurity E/ Racemic Sitagliptin | ANTI-DIABETIC | |
| 1.5 | SITAGLIPTIN | 769195-26-8 | Methly 3-Oxo-4-(2,4,5-Trifluorophenly)Butanoate | ANTI-DIABETIC | |
| 1.6 | SITAGLIPTIN | 881995-70-6 | (Z)-Methyl 3-Amino-4-(2,4,5-Trifluorophenyl)But-2-Enoate | ANTI-DIABETIC | |
| 1.7 | SITAGLIPTIN | 1234321-81-3 | (Z)Methyl 3-Acetomido-4-(2,4,5-Trifluorophenyl)But-2-Enoate | ANTI-DIABETIC | |
| 1.8 | SITAGLIPTIN | 1234321-83-5 | Sitagliptin Impurity /Methyl®-3-Acetamido-4-(2,4,5-Trifluorophenyl)Butanoate | ANTI-DIABETIC | |
| 2.1 | EMPAGLIFLOZIN | 86087-23-2 | (S)-(+)-3-Hydroxytetrahydrofuran | ANTI-DIABETIC | |
| 2.2 | EMPAGLIFLOZIN | 915095-85-1 | (5-Bromo-2-Chlorophenyl)(4-Fluorophenyl)Methanone | ANTI-DIABETIC | |
| 2.3 | EMPAGLIFLOZIN | 915095-89-5 | (3S)-3-{4-[(5-Bromo-2-Chlorophenyl)Methyl]Phenoxy}Oxolane | ANTI-DIABETIC | |
| 2.4 | EMPAGLIFLOZIN | 915095-99-7 | (2R,3R,4R,5S,6S)-3,4,5-Tris(Acetyloxy)-6-[4-Chloro-3-({4-[(3S)-Oxolan-3-Yloxy]Phenyl}Methyl)Phenyl]Oxan-2-Yl]Methyl Acetate | ANTI-DIABETIC | |
| 2.5 | EMPAGLIFLOZIN | 333361-51-6 | 4-(5-Bromo-2-Chlorobenzyl)Phenyl Methyl Ether | ANTI-DIABETIC | |
| 2.6 | EMPAGLIFLOZIN | 32384-65-9 | 2,3,4,6-Tetra-O-Trimethylsilyl-Beta-D-Glucolactone | ANTI-DIABETIC | |
| 2.7 | EMPAGLIFLOZIN | 915095-84-0 | (5-Bromo-2-Chlorophenyl)[4-[[(3S)-Tetrahydro-3-Furanyl]Oxy]Phenyl]Methyl]Methanone | ANTI-DIABETIC | |
| 2.8 | EMPAGLIFLOZIN | 915095-94-2 | (3S)-3-[4-[(2-Chloro-5-Iodophenyl)Methyl]Phenoxy]Tetrahydro-Furan | ANTI-DIABETIC | |
| 2.9 | EMPAGLIFLOZIN | 714269-57-5 | Methyl 1-C-[4-Chloro-3-[(4-Ethoxyphenyl)Methyl]Phenyl]-Alpha-D-Glucopyranoside | ANTI-DIABETIC | |
| 2.10 | EMPAGLIFLOZIN | 864070-18-8 | 4-(5-Bromo-2-Chlorobenzyl)Phenol | ANTI-DIABETIC | |
| 2.11 | EMPAGLIFLOZIN | 1103738-29-9 | 1-Chloro-2-[(4-Ethoxyphenly)Methyl]-4-Iodobenzene | ANTI-DIABETIC | |
| 3.1 | DAPAGLIFLOZIN | 461432-22-4 | (5-Bromo-2-Chlorophenyl)(4-Ethoxyphenyl)Methanone | ANTI-DIABETIC | |
| 3.2 | DAPAGLIFLOZIN | 461432-23-5 | 1-(5-Bromo-2-Chlorobenzyl)-4-Ethoxybenzene/5-Bromo-2-Chloro-4’-Ethoxydiphenylmethane | ANTI-DIABETIC | |
| 3.3 | DAPAGLIFLOZIN | 461432-24-6 | (2S,3R,4S,5S,6R)-2-{4-Chloro-3-[(4-Ethoxyphenyl)Methyl]Phenyl}-6-(Hydroxymethyl)-2-Methoxyoxane-3,4,5-Triol | ANTI-DIABETIC | |
| 3.4 | DAPAGLIFLOZIN | 461432-25-7 | [(2R,3R,4R,5S,6S)‐3,4,5‐Tris (Acetyloxy) ‐6‐{4‐Chloro‐3‐[(4‐Ethoxyphenyl) Methyl] Phenyl}Oxan‐2‐Yl]Methyl Acetate//(1S)-1,5-Anhydro-1-C-[4-Chloro-3-[(4-Ethoxyphenyl)Methyl]Phenyl]-D-Glucitol Tetraacetate | ANTI-DIABETIC | |
| 3.5 | DAPAGLIFLOZIN | 333359-90-3 | (2S,3R,4R,5S,6R)-2-{4-Chloro-3-[(4-Ethoxyphenyl)Methyl]Phenyl}-6-(Hydroxymethyl) Oxane-3,4,5-Triol | ANTI-DIABETIC | |
| 3.6 | DAPAGLIFLOZIN | 333361-51-6 | 4-Bromo-1-Chloro-2-(4-Methoxybenzyl)Benzene | ANTI-DIABETIC | |
| 3.7 | DAPAGLIFLOZIN | 714269-57-5 | Methyl 1-C-[4-Chloro-3-[(4-Ethoxyphenyl)Methyl]Phenyl]-Alpha-D-Glucopyranoside | ANTI-DIABETIC | |
| 3.8 | DAPAGLIFLOZIN | 32384-65-9 | 2,3,4,6-Tetrakis-O-Trimethylsilyl-D-Gluconolactone | ANTI-DIABETIC | |
| 3.9 | DAPAGLIFLOZIN | 333361-49-2 | (5-Bromo-2-Chlorophenyl)(4-Methoxyphenyl)-Methanone | ANTI-DIABETIC | |
| 3.10 | DAPAGLIFLOZIN | 1360568-68-8 | (5-Bromo-2-Chlorophenyl)(4-Hydroxyphenyl)Methanone | ANTI-DIABETIC | |
| 3.11 | DAPAGLIFLOZIN | 864070-18-8 | 4-(5-Bromo-2-Chlorobenzyl)Phenol | ANTI-DIABETIC | |
| 3.12 | DAPAGLIFLOZIN | 1103738-29-9 | 1-Chloro-2-[(4-Ethoxyphenyl)Methyl]-4-Iodobenzene | ANTI-DIABETIC | |
| 4.1 | APIXABAN | 1267610-26-3 | 1-(4-Amino Phenyl)-5,6-Dihydro-3-Morpholino-Pyridin-2(1H)-One | ANTI-COAGULANT | |
| 4.2 | APIXABAN | 545445-44-1 | 5,6-Dihydro-3-Morpholino-1-(4-(2-Oxo Piperidin-1-Yl) Phenyl)Pyridin)2(1H) One | ANTI-COAGULANT | |
| 4.3 | APIXABAN | 27143-07-3 | (Z)-Ethyl-2-Chloro-2-(2-(4-Methoxy Phenyl) Hydrazono Acetate/Ethyl Chloro[(4-Methoxyphenyl)Hydrazono]Acetate | ANTI-COAGULANT | |
| 4.4 | APIXABAN | 536759-91-8 | Ethyl 4,5,6,7-Tetrahydro-1-(4-Methoxyphenyl)-6-(4-Nitrophenyl)-7-Oxo-1H-Pyrazolo[3,4-C]Pyridine-3-Carboxylate//4,5,6,7-Tetrahydro-1-(4-Methoxyphenyl)-6-(4-Nitrophenyl)-7-Oxo-1H-Pyrazolo[3,4-C]Pyridine-3-Carboxylic Acid Ethyl Ester | ANTI-COAGULANT | |
| 4.5 | APIXABAN | 881386-12-5 | Ethyl 6-(4-(5-Bromopentanamido) Phenyl)-4,5,6,7-Tetrahydro-1-(4-Methoxyphenyl)-7-Oxo-1H-Pyrazolo[3,4,-C]Pyridine-3-Carboxylate | ANTI-COAGULANT | |
| 4.6 | APIXABAN | 503614-91-3 | Ethyl 1-(4-Methoxyphenyl)-7-Oxo-6-[4-(2-Oxopiperidin-1-Yl)Phenyl]-4,5,6,7-Tetrahydro-1H-Pyrazolo[3,4-C]Pyridine-3-Carboxylate | ANTI-COAGULANT | |
| 4.7 | APIXABAN | 503614-92-4 | 1-(4-Methoxyphenyl)-7-Oxo-6-(4-(2-Oxopiperidin-1-Yl)Phenyl)-4,5,6,7-Tetrahydro-1H-Pyrazolo[3,4-C]Pyridine-3-Carboxylic Acid | ANTI-COAGULANT | |
| 5.1 | RIVAROXABAN | 438056-69-0 | [4-(4-Aminophenyl)Moropholin-3-One] (KSM) | ANTI-THROMBOTIC | |
| 5.2 | RIVAROXABAN | 161596-47-0 | ([2-[(2S)-Oxiran-2-Ylmethyl]-1H-Isoindole-1,3(2H)-Dione (KSM) | ANTI-THROMBOTIC | |
| 5.3 | RIVAROXABAN | 24065-33-6 | 5-Chlorothiophene-2-Carboxyilic Acid (KSM) | ANTI-THROMBOTIC | |
| 5.4 | RIVAROXABAN | 446292-07-5 | 2-[(2R)-2-Hydroxy-3-{[4-(3-Oxomorpholin -4-Yl) Phenyl]Amino}Propyl]-1H-Isoindole-1,3(2H)-Dione | ANTI-THROMBOTIC | |
| 5.5 | RIVAROXABAN | 446292-08-6 | 2-({(5S)-2-Oxo-3-[4-(3-Oxomorpholin-4-Yl)Phenyl]-1,3-Oxazolidin-5-Yl}Methyl)-1H-Isoindole-1,3(2H)-Dione | ANTI-THROMBOTIC | |
| 5.6 | RIVAROXABAN | 898543-06-1 | 4-{4-[(5S)-5-(Aminomethyl)-2-Oxo-1,3-Oxazolidin-3-Yl]Phenyl}Morpholin-3-One Hydrochloride. | ANTI-THROMBOTIC | |
| 6.1 | DABIGATRAN | 103041-38-9 | Ethyl-3-(Pyridin-2Yl-Amino) Propionate. | ANTI-THROMBOTIC | |
| 6.2 | DABIGATRAN | 42288-26-6 | 4-Cyano Phenyl Glycine. | ANTI-THROMBOTIC | |
| 6.3 | DABIGATRAN | 212322-56-0 | 3-[(3-A-4-Mab Pyridine-2-Ylamino]Propionicacid Ethyl Ester | ANTI-THROMBOTIC | |
| 6.4 | DABIGATRAN | 873-74-5 | 4-Amino Benzonitrile. | ANTI-THROMBOTIC | |
| 6.5 | DABIGATRAN | 1307233-94-8 | Ethyl-3-(2-Chloro Methyl)-1-Methyl-N-(Pyridin-2Yl)-1H-Benzo (D)-Imidazole-5-Carboxamido Propanoate | ANTI-THROMBOTIC | |
| 6.6 | DABIGATRAN | 277319-62-7 | 4-Amino-N-Hydroxy Benzimidamide | ANTI-THROMBOTIC | |
| 6.7 | DABIGATRAN | 1307233-93-7 | Hexyl Amino-4-Amino Phenyl Methylene Carbamate | ANTI-THROMBOTIC | |
| 6.8 | DABIGATRAN | 211915-06-9 | Dabigatran Etexilate | ANTI-THROMBOTIC | |
| 6.9 | DABIGATRAN | 872728-81-9 | Dabigatran Etexilate Mesylate | ANTI-THROMBOTIC | |
| 6.10 | DABIGATRAN | 211915-84-3 | Ethyl 3-(2-(((4-Cyanophenyl) Amino)Methyl)-1-Methyl-N-(Pyridin-2-Yl)-1H-Benzo [D]Imidazole-5-Carboxamido)Propanoate | ANTI-THROMBOTIC | |
| 6.11 | DABIGATRAN | 211915-06-9 | Ethyl 3-[[[2-[[[4-[[[(Hexyloxy)Carbonyl]Amino]Iminomethyl]Phenyl] Amino]Methyl]-1-Methyl-1H-Benzimidazol-5-Yl]Carbonyl](Pyridine-2-Yl)Amino]Propanoate | ANTI-THROMBOTIC | |
| 6.12 | DABIGATRAN | 1229006-21-6 | Methyl 5-(2,4-Difluorobenzylcarbamoyl) -3-(Benzyloxy)-1,4-Dihydro-1-(2,2-Dimethoxyethyl)-4-Oxopyridine-2-Carboxylate. | ANTI-THROMBOTIC | |
| 6.13 | DABIGATRAN | 1206102-11-5 | (4R,12As)-N-(2,4-Difluorobenzyl)-7-Benzyloxy-4-Methyl-6,8-Dioxo-3,4,6,8,12,12A-Hexahydro-2H-Pyrido[1',2':4,5]Pyrazino[2,1-B][1,3]Oxazine-9-Carboxamide | ANTI-THROMBOTIC | |
| 6.14 | DABIGATRAN | 1051375-16-6 | (4R,12As)-N-(2,4-Difluorobenzyl)-7-Hydroxy-4-Methyl-6,8-Dioxo-3,4,6,8,12,12A-Hexahydro-2H-Pyrido[1',2':4,5]Pyrazino[2,1-B][1,3]Oxazine-9-Carboxamide | ANTI-THROMBOTIC | |
| 6.15 | DABIGATRAN | 1246616-66-9 | Dimethyl 3-(Benzyloxy)-4-Oxo-4H-Pyran-2,5-Dicarboxylate | ANTI-THROMBOTIC | |
| 7.1 | CELECOXIB | 17852-52-7 | 4-Hydrazino Benzene Sulphonomide Hcl | ANTI-INFLAMMATORY | |
| 7.2 | CELECOXIB | 720-94-5 | 4,4,4-Trifluoro 1-(4 Methylphenyl) Butane -1,3-Dione | ANTI-INFLAMMATORY | |
| 7.3 | CELECOXIB | 122-00-9 | 4-Methyl Aceto Phenone(KSM) | ANTI-INFLAMMATORY | |
